tiprankstipranks
Forma Therapeutics Holdings (FMTX)
NASDAQ:FMTX
US Market
Holding FMTX?
Track your performance easily

Forma Therapeutics Holdings (FMTX) Income Statement

0 Followers

Forma Therapeutics Holdings Income Statement

Last quarter (Q ), Forma Therapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Forma Therapeutics Holdings's net income was $-52.58M. See Forma Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18
Total Revenue
-$ 0.00$ 0.00$ 100.56M$ 164.09M
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 191.13M$ 173.99M$ 124.15M$ 135.72M$ 154.40M
Operating Income
$ -191.13M$ -173.99M$ -124.15M$ -35.16M$ 9.69M
Net Non Operating Interest Income Expense
$ 1.39M$ 1.05M$ 3.43M$ 2.85M$ 3.69M
Other Income Expense
$ -390.00K$ 122.00K$ 20.59M$ -4.33M$ 482.00K
Pretax Income
$ -190.13M$ -172.81M$ -100.13M$ -36.64M$ 13.86M
Tax Provision
$ 28.00K$ 154.00K$ -29.72M$ -1.85M$ 8.57M
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -190.16M$ -172.96M$ -74.15M$ -52.75M$ 93.00K
Basic EPS
$ -4.00$ -3.65$ -3.22$ -3.15$ <0.01
Diluted EPS
$ -4.00$ -3.65$ -3.22$ -3.15$ -0.03
Basic Average Shares
$ 190.12M$ 47.35M$ 23.06M$ 11.37M$ 11.37M
Diluted Average Shares
$ 190.12M$ 47.35M$ 23.06M$ 11.37M$ 11.37M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 191.13M$ 173.99M$ 124.15M$ 135.72M$ 154.40M
Net Income From Continuing And Discontinued Operation
$ -190.16M$ -172.96M$ -70.41M$ -34.79M$ 5.29M
Normalized Income
$ -189.95M$ -172.96M$ -86.76M$ -29.77M$ 5.29M
Interest Expense
-----
EBIT
$ -191.13M$ -173.99M$ -124.15M$ -35.16M$ 9.69M
EBITDA
$ -188.56M$ -172.42M$ -122.87M$ -32.49M$ 13.22M
Currency in USD

Forma Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis